(Q33775866)

29 July 2017

title

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients (English)

1 reference

29 July 2017

0 references

fluticasone propionate

1 reference

Clark DJ

1 reference

29 July 2017

Grove A

series ordinal

1 reference

29 July 2017

Cargill RI

series ordinal

1 reference

29 July 2017

Lipworth BJ

series ordinal

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

262-266

1 reference

Clinical pharmacology of corticosteroids in bronchial asthma

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1090636

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1090636

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1090636

A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1090636

An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1090636

Binding kinetics of fluticasone propionate to the human glucocorticoid receptor

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1090636

New perspectives on inhaled drug delivery and systemic bioactivity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1090636

The human pharmacology of fluticasone propionate

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1090636

High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society

4 July 2018

1 reference

12 December 2020

High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group

1 reference

12 December 2020

Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid

1 reference

12 December 2020

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

12 December 2020

A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma

1 reference

12 December 2020

Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.51.3.262

1 reference

29 July 2017

1 reference

29 July 2017

1 reference